DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Anti-CD3 Therapy
 
Diabetes OD > Reversal/Prevention of Diabetes > T1DM > Re-establishing Tolerance > Modifying Immunity > Recent Onset > Systemic Intervention > T cells > Anti-CD3 Therapy

Anti-CD3 Therapy


(Journal Article): Questioning Four Preconceived Ideas on Immunotherapy of Clinical Type 1 Diabetes: Lessons from Recent CD3 Antibody Trials
 
Chatenoud L, Bach JF
 
IN: Rev Diabetic Stud 2005; 2(3):116-120
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

ABSTRACT: n.a. Click HERE for details

 

(Journal Article): Insulin-dependent diabetes mellitus as an autoimmune disease.
 
Bach JF
 
IN: Endocr Rev 1994; 15(4):516-542
Impact Factor(s) of Endocr Rev: 18.784 (2004), 17.324 (2003), 21.643 (2002), 26.456 (2001)

ABSTRACT: IDDM is unquestionably an autoimmune disease, as reflected by the presence of beta-cell-reactive autoantibodies and T cells, T cell-mediated transfer of the disease in nondiabetic ... Click HERE for details

 

(Journal Article): Limitations in Immunotherapy with CD3 Antibodies: Comment on the Article by Drs. Chatenoud and Bach
 
Bresson D, von Herrath M
 
IN: Rev Diabetic Stud 2005; 20(4):187-189
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

ABSTRACT: n.a. Click HERE for details

 

(Journal Article): Response to the Comment by D. Bresson and M. von Herrath
 
Chatenoud L, Bach JF
 
IN: Rev Diabetic Stud 2005; 2(4):190-191
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

ABSTRACT: n.a. Click HERE for details

 



 
Contribute to this subject area!